Protein Kinases as Drug Targets PDF ePub eBook

Books Info:

Protein Kinases as Drug Targets free pdf This timely guide to kinase inhibitor drug development is the first to cover the entire drug pipeline, from target identification to compound development and clinical application. Edited by the pioneers in the field, on the drug development side this ready reference discusses classical medicinal chemistry approaches as well as current chemical genomics strategies. On the clinical side, both current and future therapeutic application areas for kinase inhibitor drugs are addressed, with a strong focus on oncology drugs. Backed by recent clinical experience with first-generation drugs in the battle against various forms of cancer, this is crucial reading for medicinal, pharmaceutical and biochemists, molecular biologists, and oncologists, as well as those working in the pharmaceutical industry.

About Gerhard Muller

Bert Klebl is an expert in small molecule based drug discovery. Currently, he is managing director and CSO of Lead Discovery Center GmbH, which was started by Max-Planck Innovation and the Max-Planck Society. Before, he was at GPC Biotech, Axxima Pharmaceuticals and Aventis (Hoechst Marion Roussel). A biochemist by training, he graduated from the University of Konstanz, Germany, and did post-doctoral work at the Biotechnology Research Institute in Montreal, Canada. Gerhard Muller received his PhD in Organic Chemistry in 1992 from the Technical University of Munich, working with Horst Kessler. After two years in the Medicinal Chemistry Department of Glaxo Verona (Italy), he joined the Central Research Facility of Bayer AG in Leverkusen. From 2001 to 2003 he headed the chemistry department of Organon's Lead Discovery Unit is Oss, Netherlands. In 2003 he was nominated CSO of Axxima Pharmaceuticals AG in Munich, and upon its acquisition through GPC Biotech AG in 2005, he became GPC's Vice President Drug Discovery. Since 2008 he is CSO and Managing Director of Proteros Fragments GmbH, specializing in fragment-based lead generation. Apart from numerous scientific articles and patents, he co-edited the "Chemogenomics in Drug Discovery" book of this series on medicinal chemistry. Michael Hamacher studied biology at the Heinrich-Heine-Universitat in Dusseldorf, Germany. Subsequent to his PhD, he joined the Medizinisches Proteom-Center, Ruhr-Universitat Bochum, Germany, and became Head of Administration of the MPC, responsible for the implementation and the strategical planning of the Human Brain Proteome Project under the roof of the Human Proteome Organisation (HUPO BPP) among others. In 2008, he moved to the Lead Discovery Center GmbH, Dortmund, Germany, for the same position, focussing on preparing national as well as international funding applications, on project management, budgeting as well as human resources. He applied and implemented numerous projects in early pharmaceutical research.

Details Book

Author : Gerhard Muller
Publisher : Wiley-VCH Verlag GmbH
Data Published : 09 February 2011
ISBN : 3527317902
EAN : 9783527317905
Format Book : PDF, Epub, DOCx, TXT
Number of Pages : 396 pages
Age + : 15 years
Language : English
Rating :

Reviews Protein Kinases as Drug Targets



17 Comments Add a comment




Related eBooks Download


  • Cancer Drug Resistance free pdfCancer Drug Resistance

    This volume discusses the latest advancements and technologies used in cancer drug resistance research. Cancer Drug Resistance: Overviews and Methods contains chapters that cover topics such as: studying the mechanics of resistance to DNA damaging therapeutic drugs- studies to delineate the role of efflux transporters- expression of drug transporters- resistance to targeted therapies in breast cancer- the role of microRNAs in current pancreatic cancer treatment- and cancer exosomes as mediators of drug resistance or clinical and molecular methods in drug development and the use of bioinformatics in the management of cancer drug resistance data..


  • Research Frontiers Drug Addiction free pdfResearch Frontiers Drug Addiction

    This volume brings together basic and clinical science to provide in-depth understanding and current knowledge concerning new conceptual insights into the CNS acting drugs and drugs of abuse and treatment of drug addiction..


  • Pharmacokinetic Challenges in Drug Discovery free pdfPharmacokinetic Challenges in Drug Discovery

    Despite increased spending on research and development. the number of new medicines marketed successfully continues to decline. The Pharmaceutical industry is therefore focussing on ways to reduce attrition by addressing frequent reasons for clinical drug failures very early in the drug discovery process..


  • Proteins  free pdfProteins

    The books in this set cover important protein drug targets. current drug leads. and biological mechanisms underpinning cutting-edge therapeutic strategies. At the interface between chemical biology..


  • In Silico Technologies in Drug Target Identification and Validation free pdfIn Silico Technologies in Drug Target Identification and Validation

    The pharmaceutical industry relies on numerous well-designed experiments involving high-throughput techniques and in silico approaches to analyze potential drug targets..


  • Protein Kinases as Drug Targets free pdfProtein Kinases as Drug Targets

    Free Computer Ebooks Download. This timely guide to kinase inhibitor drug development is the first to cover the entire drug pipeline, from target identification to compound development and clinical ap